Skip to Main Content

Paper Details

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.
Cureus
37
2015
Author NameAffiliation
Vishesh KhannaKnight Cancer Institute, Oregon Health & Science University Howard Hughes Medical Institute Medical Research Fellows Program, Howard Hughes Medical Institute Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
Kim-Hien T DaoKnight Cancer Institute, Oregon Health & Science University.
Cristina E TognonKnight Cancer Institute, Oregon Health & Science University.
Brian JunioKnight Cancer Institute, Oregon Health & Science University.
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University.
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University Howard Hughes Medical Institute Investigator Program, Howard Hughes Medical Institute Division of Hematology & Medical Oncology, Oregon Health & Science University Department of Cell, Oregon Health & Science University.
  • 1 - 6

Datasets